Back in August of 2016, the pharmaceutical company Mylan came under fire for jacking up prices of the EpiPen from $57 in 2007 to roughly $600 in 2016. The public backlash has been significant. Gizmodo adds: But the chairman of Mylan has a message for any critics: Go fuck yourself. Well, at least that's what we think he said. The New York Times has a new article about the fact that prices for the live-saving allergy medication haven't actually come down since last year. And the article has a rather strange way of describing the attitude of Mylan chairman Robert Coury. This is how the New York Times describes Coury's reaction to critics of Mylan's price gouging: "Mr. Coury replied that he was untroubled. He raised both his middle fingers and explained, using colorful language, that anyone criticizing Mylan, including its employees, ought to go copulate with themselves. Critics in Congress and on Wall Street, he said, should do the same. And regulators at the Food and Drug Administration? They, too, deserved a round of anatomically challenging self-fulfillment."